相关实验视频

Updated: Jun 26, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

用化学抗原受体武装Vδ2 T细胞,对抗癌症

Pauline Thomas¹, Pierre Paris¹, Claire Pecqueur¹

¹Nantes Université, CRCI2NA, INSERM, CNRS, Nantes, France.

Clinical cancer research : an official journal of the American Association for Cancer Research

|May 15, 2024

概括

化学抗原受体 (CAR) T细胞疗法对癌症具有前景. 武装马三角T细胞为下一代针对固体瘤的免疫疗法提供了一种新方法.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

化学抗原受体 (CAR) T细胞疗法是一种成功的癌症免疫疗法.
限制包括瘤抗原异质性,免疫逃避和有限的CAR-T细胞持久性.
马三角形 (γδ) T 细胞提供固有的瘤识别和多功能性免疫功能.

研究的目的:

探索Vδ2 T细胞作为下一代针对固体瘤的免疫疗法的基础.
审查 γδ T 细胞生物学和创新的 CAR 工程战略.
讨论Vδ2 CAR-T细胞在克服免疫治疗局限性的临床潜力.

主要方法:

关于 γδ T 细胞生物学的全面概述.
对Vδ2 T细胞的创新CAR工程策略的审查.
讨论临床潜力和挑战.

主要成果:

Vδ2 T 细胞具有固有的瘤识别和多功能性免疫功能.
汽车工程可以提高Vδ2T细胞的疗效.
Vδ2 CAR-T细胞显示出解决固体瘤免疫疗法的局限性的潜力.

结论:

Vδ2 T 细胞是下一代癌症免疫疗法的一个有希望的平台.
需要进一步的研究来识别和克服Vδ2 CAR-T细胞应用中的挑战.
Vδ2 CAR-T 细胞代表了固体瘤治疗的潜在突破.

更多相关视频

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...